| Synthesis of giant globular multivalent glycofullerenes as potent inhibitors in a model of Ebola virus infection A Muñoz, D Sigwalt, BM Illescas, J Luczkowiak, L Rodriguez-Perez, ... Nature chemistry 8 (1), 50, 2016 | 307 | 2016 |
| DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist M Thépaut, J Luczkowiak, C Vivès, N Labiod, I Bally, F Lasala, Y Grimoire, ... | 175 | 2020 |
| Glycofullerenes inhibit viral infection J Luczkowiak, A Muñoz, M Sánchez-Navarro, R Ribeiro-Viana, A Ginieis, ... Biomacromolecules 14 (2), 431-437, 2013 | 164 | 2013 |
| Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection R Ribeiro-Viana, M Sánchez-Navarro, J Luczkowiak, JR Koeppe, ... Nature communications 3 (1), 1-9, 2012 | 161 | 2012 |
| Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection J Luczkowiak, S Sattin, I Sutkeviciute, JJ Reina, M Sánchez-Navarro, ... Bioconjugate chemistry 22 (7), 1354-1365, 2011 | 114 | 2011 |
| Nanocarbon-based glycoconjugates as multivalent inhibitors of Ebola virus infection L Rodríguez-Pérez, J Ramos-Soriano, A Pérez-Sánchez, BM Illescas, ... Journal of the American Chemical Society 140 (31), 9891-9898, 2018 | 70 | 2018 |
| Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19 MD Folgueira, J Luczkowiak, F Lasala, A Pérez-Rivilla, R Delgado Clinical Microbiology and Infection, 2021 | 57 | 2021 |
| Antiviral activity of self-assembled glycodendro [60] fullerene monoadducts A Muñoz, BM Illescas, J Luczkowiak, F Lasala, R Ribeiro-Viana, J Rojo, ... Journal of Materials Chemistry B 5 (32), 6566-6571, 2017 | 49 | 2017 |
| Seroprevalence analysis of SARS-CoV-2 in pregnant women along the first pandemic outbreak and perinatal outcome C Villalaín, I Herraiz, J Luczkowiak, A Pérez-Rivilla, MD Folgueira, I Mejía, ... PloS one 15 (11), e0243029, 2020 | 36 | 2020 |
| Convalescent Plasma for Ebola Virus Disease. DR Arribas JR, Luczkowiak J N Engl J Med 374 (25), 2498-2499, 2016 | 33* | 2016 |
| Persistent SARS-CoV-2 replication in severe COVID-19 MD Folgueira, J Luczkowiak, F Lasala, A Perez-Rivilla, R Delgado medRxiv, 2020 | 32 | 2020 |
| Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus J Luczkowiak, JR Arribas, S Gómez, V Jiménez-Yuste, F de la Calle, ... Virus research 213, 224-229, 2016 | 27 | 2016 |
| Detection of HIV-1 at between 20 and 49 copies per milliliter by the Cobas TaqMan HIV-1 v2. 0 assay is associated with higher pretherapy viral load and less time on … JF Pascual-Pareja, L Martínez-Prats, J Luczkowiak, S Fiorante, R Rubio, ... Journal of clinical microbiology 48 (5), 1911-1912, 2010 | 25 | 2010 |
| Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV‐1 RN ase H inhibitors P Gao, X Wang, L Sun, X Cheng, V Poongavanam, J Kongsted, M Álvarez, ... Chemical biology & drug design 93 (4), 582-589, 2019 | 18 | 2019 |
| Identification Of Potential Inhibitors Of Protein-Protein Interaction Useful To Fight Against Ebola And Other Highly Pathogenic Viruses F Lasala, A García-Rubia, C Requena, I Galindo, MA Cuesta-Geijo, ... Antiviral Research, 105011, 0 | 18 | |
| Unprecedented Thiacalixarene Fucoclusters as Strong Inhibitors of Ebola cis-Cell Infection and HCMV-gB Glycoprotein/DC-SIGN C-type Lectin Interaction M Taouai, V Porkolab, K Chakroun, C Cheneau, J Luczkowiak, R Abidi, ... Bioconjugate chemistry 30 (4), 1114-1126, 2019 | 17 | 2019 |
| No xenotropic murine leukemia virus–related virus detected in fibromyalgia patients J Luczkowiak, O Sierra, JJ González-Martín, G Herrero-Beaumont, ... Emerging infectious diseases 17 (2), 314, 2011 | 17 | 2011 |
| Broad neutralizing activity against ebolaviruses lacking the mucin-like domain in convalescent plasma specimens from patients with Ebola virus disease J Luczkowiak, F Lasala, M Mora-Rillo, JR Arribas, R Delgado The Journal of infectious diseases 218 (suppl_5), S574-S581, 2018 | 14 | 2018 |
| Design, synthesis and biological evaluation of 3-hydroxyquinazoline-2, 4 (1H, 3H)-diones as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and integrase P Gao, X Cheng, L Sun, S Song, M Álvarez, J Luczkowiak, ... Bioorganic & medicinal chemistry 27 (17), 3836-3845, 2019 | 13 | 2019 |
| DNA-Dependent DNA Polymerases as Drug Targets in Herpesviruses and Poxviruses J Luczkowiak, M Álvarez, A Sebastián-Martín, L Menéndez-Arias Viral Polymerases, 95-134, 2019 | 12 | 2019 |
